This is not what disruption looks like. This is what happens when you have someone with no domain expertise, but a great idea. We're seeing the same thing happening with Zenefits. Founders with no domain experience need to look at how they're going to enter a market full of incumbents. These incumbent businesses have survived for years because they know how to play the game. They have people in their employ that know how to lobby the right regulatory bodies. Theranos had none of this. So when all of this started coming down, they should have hired the most well-known and respected person in their field to bridge the gap between the past and future. Without that, they are outsiders playing in a game that has been around forever. They were set up for failure before they even began and no one was smart enough to ask "How will they disrupt an industry that has been around for decades?" Just saying, "We're going to make medical tests cheaper and more accessible" was clearly not the right answer.